Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Carotid Atherosclerosis: early-phase trial registry
2 of 6 indexed Carotid Atherosclerosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Carotid Atherosclerosis: 6 US clinical trials tracked, 2 recruiting.
Carotid Atherosclerosis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 3 of these trials.
Enrollment posture brief
Registry condition carotid-atherosclerosis
OPEN 2 | RECR 33% | LATE 1 | EARLY 3 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Carotid Atherosclerosis lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Carotid Atherosclerosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Carotid Atherosclerosis is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Carotid Atherosclerosis research.
Washington University School of Medicine accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Carotid Atherosclerosis enrolment sits around 100 participants.
Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Carotid Atherosclerosis splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
PET Detection of CCR2 in Human Atherosclerosis
Washington University School of Medicine
NCT04537403
CANF-Comb-II PET-MR in Atherosclerosis Multisite
Washington University School of Medicine
NCT05838547
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
Thomas Jefferson University
NCT04643431
Potential Risk Factors for Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001368
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
National Institutes of Health Clinical Center (CC)
NCT00001589
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
Washington University School of Medicine
NCT02417688
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Carotid Atherosclerosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Carotid Atherosclerosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Carotid Atherosclerosis page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Carotid Atherosclerosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Washington University School of Medicine sponsors the most Carotid Atherosclerosis trials on record, review their full trial history before evaluating a specific study. See Washington University School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Carotid Atherosclerosis condition card totals 6 registered trials; most-linked intervention Cu[64]-25%-CANF-Comb PET-MR; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.